HEADER OXIDOREDUCTASE 17-OCT-06 2ISF TITLE CRYSTAL STRUCTURE OF C298A W219Y ALDOSE REDUCTASE COMPLEXED WITH TITLE 2 PHENYLACETIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALDOSE REDUCTASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: AR, ALDEHYDE REDUCTASE; COMPND 5 EC: 1.1.1.21; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKR1B1, ALDR1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET KEYWDS TIM-BARREL, ARI, ALDO-KETO REDUCTASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR D.H.T.HARRISON,E.PAPE,J.M.BROWNLEE REVDAT 5 30-AUG-23 2ISF 1 REMARK REVDAT 4 20-OCT-21 2ISF 1 REMARK SEQADV REVDAT 3 18-OCT-17 2ISF 1 REMARK REVDAT 2 24-FEB-09 2ISF 1 VERSN REVDAT 1 28-NOV-06 2ISF 0 JRNL AUTH J.M.BROWNLEE,E.CARLSON,A.C.MILNE,E.PAPE,D.H.HARRISON JRNL TITL STRUCTURAL AND THERMODYNAMIC STUDIES OF SIMPLE ALDOSE JRNL TITL 2 REDUCTASE-INHIBITOR COMPLEXES. JRNL REF BIOORG.CHEM. V. 34 424 2006 JRNL REFN ISSN 0045-2068 JRNL PMID 17083960 JRNL DOI 10.1016/J.BIOORG.2006.09.004 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 82.4 REMARK 3 NUMBER OF REFLECTIONS : 17635 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.209 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 848 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2509 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 58 REMARK 3 SOLVENT ATOMS : 114 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 9.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ISF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-OCT-06. REMARK 100 THE DEPOSITION ID IS D_1000039957. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-NOV-98 REMARK 200 TEMPERATURE (KELVIN) : 277 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18241 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 85.2 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.06700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.03 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.34 REMARK 200 R MERGE FOR SHELL (I) : 0.27800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.630 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1AZ1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 % PEG 6000, 50 MM CITRATE, REMARK 280 SUBSEQUENT GLUTARALDEHYDE X-LINK, LIGAND SOAK, PH 5.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.03500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.05900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.42100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.05900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.03500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.42100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 21 1.94 82.42 REMARK 500 ALA A 45 140.56 -173.82 REMARK 500 ASN A 50 15.22 -143.00 REMARK 500 ASP A 125 -163.77 -101.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAP A 316 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PAC A 317 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2IPW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF C298A W219Y ALDOSE REDUCTASE COMPLEXED WITH REMARK 900 DICHLOROPHENYLACETIC ACID REMARK 900 RELATED ID: 2INE RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH PHENYLACETIC REMARK 900 ACID REMARK 900 RELATED ID: 2INZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH 2- REMARK 900 HYDROXYPHENYLACETIC ACID REMARK 900 RELATED ID: 2IQ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH HEXANOIC ACID REMARK 900 RELATED ID: 2IQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH LIPOIC ACID REMARK 900 RELATED ID: 2IS7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ALDOSE REDUCTASE COMPLEXED WITH REMARK 900 DICHLOROPHENYLACETIC ACID DBREF 2ISF A 1 315 UNP P15121 ALDR_HUMAN 1 315 SEQADV 2ISF TYR A 219 UNP P15121 TRP 219 ENGINEERED MUTATION SEQADV 2ISF ALA A 298 UNP P15121 CYS 298 ENGINEERED MUTATION SEQRES 1 A 315 ALA SER ARG LEU LEU LEU ASN ASN GLY ALA LYS MET PRO SEQRES 2 A 315 ILE LEU GLY LEU GLY THR TRP LYS SER PRO PRO GLY GLN SEQRES 3 A 315 VAL THR GLU ALA VAL LYS VAL ALA ILE ASP VAL GLY TYR SEQRES 4 A 315 ARG HIS ILE ASP CYS ALA HIS VAL TYR GLN ASN GLU ASN SEQRES 5 A 315 GLU VAL GLY VAL ALA ILE GLN GLU LYS LEU ARG GLU GLN SEQRES 6 A 315 VAL VAL LYS ARG GLU GLU LEU PHE ILE VAL SER LYS LEU SEQRES 7 A 315 TRP CYS THR TYR HIS GLU LYS GLY LEU VAL LYS GLY ALA SEQRES 8 A 315 CYS GLN LYS THR LEU SER ASP LEU LYS LEU ASP TYR LEU SEQRES 9 A 315 ASP LEU TYR LEU ILE HIS TRP PRO THR GLY PHE LYS PRO SEQRES 10 A 315 GLY LYS GLU PHE PHE PRO LEU ASP GLU SER GLY ASN VAL SEQRES 11 A 315 VAL PRO SER ASP THR ASN ILE LEU ASP THR TRP ALA ALA SEQRES 12 A 315 MET GLU GLU LEU VAL ASP GLU GLY LEU VAL LYS ALA ILE SEQRES 13 A 315 GLY ILE SER ASN PHE ASN HIS LEU GLN VAL GLU MET ILE SEQRES 14 A 315 LEU ASN LYS PRO GLY LEU LYS TYR LYS PRO ALA VAL ASN SEQRES 15 A 315 GLN ILE GLU CYS HIS PRO TYR LEU THR GLN GLU LYS LEU SEQRES 16 A 315 ILE GLN TYR CYS GLN SER LYS GLY ILE VAL VAL THR ALA SEQRES 17 A 315 TYR SER PRO LEU GLY SER PRO ASP ARG PRO TYR ALA LYS SEQRES 18 A 315 PRO GLU ASP PRO SER LEU LEU GLU ASP PRO ARG ILE LYS SEQRES 19 A 315 ALA ILE ALA ALA LYS HIS ASN LYS THR THR ALA GLN VAL SEQRES 20 A 315 LEU ILE ARG PHE PRO MET GLN ARG ASN LEU VAL VAL ILE SEQRES 21 A 315 PRO LYS SER VAL THR PRO GLU ARG ILE ALA GLU ASN PHE SEQRES 22 A 315 LYS VAL PHE ASP PHE GLU LEU SER SER GLN ASP MET THR SEQRES 23 A 315 THR LEU LEU SER TYR ASN ARG ASN TRP ARG VAL ALA ALA SEQRES 24 A 315 LEU LEU SER CYS THR SER HIS LYS ASP TYR PRO PHE HIS SEQRES 25 A 315 GLU GLU PHE HET NAP A 316 48 HET PAC A 317 10 HETNAM NAP NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE HETNAM PAC 2-PHENYLACETIC ACID HETSYN NAP 2'-MONOPHOSPHOADENOSINE 5'-DIPHOSPHORIBOSE FORMUL 2 NAP C21 H28 N7 O17 P3 FORMUL 3 PAC C8 H8 O2 FORMUL 4 HOH *114(H2 O) HELIX 1 1 PRO A 23 GLY A 38 1 16 HELIX 2 2 ALA A 45 GLN A 49 5 5 HELIX 3 3 ASN A 50 GLU A 64 1 15 HELIX 4 4 LYS A 68 LEU A 72 5 5 HELIX 5 5 TRP A 79 HIS A 83 5 5 HELIX 6 6 GLU A 84 GLY A 86 5 3 HELIX 7 7 LEU A 87 LYS A 100 1 14 HELIX 8 8 ASN A 136 GLU A 150 1 15 HELIX 9 9 ASN A 162 ASN A 171 1 10 HELIX 10 10 GLN A 192 LYS A 202 1 11 HELIX 11 11 ASP A 230 HIS A 240 1 11 HELIX 12 12 THR A 243 GLN A 254 1 12 HELIX 13 13 THR A 265 ASN A 272 1 8 HELIX 14 14 SER A 281 SER A 290 1 10 HELIX 15 15 LEU A 300 THR A 304 5 5 SHEET 1 A 2 ARG A 3 LEU A 5 0 SHEET 2 A 2 LYS A 11 PRO A 13 -1 O MET A 12 N LEU A 4 SHEET 1 B 8 LEU A 17 GLY A 18 0 SHEET 2 B 8 HIS A 41 ASP A 43 1 O ASP A 43 N LEU A 17 SHEET 3 B 8 PHE A 73 LEU A 78 1 O VAL A 75 N ILE A 42 SHEET 4 B 8 LEU A 106 ILE A 109 1 O LEU A 108 N LEU A 78 SHEET 5 B 8 ILE A 156 SER A 159 1 O GLY A 157 N TYR A 107 SHEET 6 B 8 VAL A 181 GLU A 185 1 O VAL A 181 N ILE A 158 SHEET 7 B 8 VAL A 205 TYR A 209 1 O THR A 207 N ILE A 184 SHEET 8 B 8 VAL A 258 VAL A 259 1 O VAL A 258 N ALA A 208 SITE 1 AC1 34 GLY A 18 THR A 19 TRP A 20 LYS A 21 SITE 2 AC1 34 ASP A 43 TYR A 48 LYS A 77 HIS A 110 SITE 3 AC1 34 SER A 159 ASN A 160 GLN A 183 TYR A 209 SITE 4 AC1 34 SER A 210 PRO A 211 LEU A 212 GLY A 213 SITE 5 AC1 34 SER A 214 PRO A 215 ASP A 216 LEU A 228 SITE 6 AC1 34 ALA A 245 ILE A 260 PRO A 261 LYS A 262 SITE 7 AC1 34 SER A 263 VAL A 264 THR A 265 ARG A 268 SITE 8 AC1 34 GLU A 271 ASN A 272 PAC A 317 HOH A 533 SITE 9 AC1 34 HOH A 535 HOH A 618 SITE 1 AC2 5 TRP A 20 TYR A 48 HIS A 110 TRP A 111 SITE 2 AC2 5 NAP A 316 CRYST1 50.070 66.842 92.118 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019972 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014961 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010856 0.00000